Boehringer Ingelheim RCV (Regional Center Vienna) – Operating in over 30 countries
The Regional Center Vienna (RCV), part of the German pharmaceutical company Boehringer Ingelheim, is responsible for over 30 countries in Central and Eastern Europe and in Asia. It is thus one of the company’s most important sites and is also a flagship enterprise in the Austrian capital. It employs around 1,500 people in medical research, production and administration.
As the center of Boehringer Ingelheim’s oncology research, Boehringer Ingelheim RCV GmbH & Co KG in Vienna is one of the most important sites within the global group of companies. We carry out research on new substances for cancer and other diseases and test them in clinical trials. The second focus is the development and production of biopharmaceuticals for ourselves and others.
As a regional center, we are responsible not only for the Austrian market but also for 33 countries in Central and Eastern Europe as far as Russia and Mongolia, and also Israel.
Our common goal is to achieve breakthroughs in the treatment of diseases and to advance medical research.